SCHEMBL4015374

SCHEMBL4015374

CCOC(=O)COc1cc(OC)c(Cl)cc1C(=O)c1ccc(F)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.47
▸ CNR2 P34972 1/20 0.45
▸ HPGD P15428 3/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ ALDH1A1 P00352 4/20 0.44
▸ GAA P10253 3/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ CXCR1 P25024 1/20 0.42
▸ CXCR2 P25025 1/20 0.42
▸ MAPT P10636 2/20 0.41
▸ NPSR1 Q6W5P4 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ PPOX P50336 1/20 0.41
▸ ALOX15 P16050 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3646323 0.89 HPGD (0.58) KDM4EHPGDSMN1; SMN2ALDH1A1GAA
SCHEMBL3644177 0.83 KDM4E (0.60) KDM4EHPGDSMN1; SMN2ALDH1A1GAA
SCHEMBL14419295 0.83 MAPT (0.50) HPGDSMN1; SMN2ALDH1A1GAAKMT2A
SCHEMBL3645549 0.81 TSHR (0.49) ALDH1A1GAAKMT2AL3MBTL1TDP1
SCHEMBL14419477 0.81 MAPT (0.50) KDM4EHPGDALDH1A1GAAKMT2A
SCHEMBL3646038 0.78 L3MBTL1 (0.47) ALDH1A1GAAKMT2AL3MBTL1TDP1
SCHEMBL28047078 0.76 TSHR (0.49) ALDH1A1GAAKMT2AL3MBTL1TDP1
SCHEMBL3644276 0.76 SMN1; SMN2 (0.54) KDM4EHPGDSMN1; SMN2ALDH1A1GAA
SCHEMBL3644278 0.76 MAPT (0.58) KDM4EHPGDSMN1; SMN2ALDH1A1GAA
SCHEMBL14419231 0.74 ALDH1A1 (0.47) KDM4EHPGDSMN1; SMN2ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7534788-B2 Benzofuran and benzothiophene-2-carboxylic acid amide derivatives HOFFMANN-LA ROCHE INC. (US) 2009-05-19 — — US disclosed
US-20090029976-A1 BENZOFURAN AND BENZOTHIOPHENE-2-CARBOXYLIC ACID AMIDE DERIVATIVES HOFFMANN-LA ROCHE, INC. 2009-01-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090029976-A1 BENZOFURAN AND BENZOTHIOPHENE-2-CARBOXYLIC ACID AMIDE DERIVATIVES HCAR2, HCAR1, HRH3 KDM4E 793/4885CNR2 112/4885HPGD 1791/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback